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angiography (CA) and percutaneous coronary intervention (PCI) Methods: Sixty consecutive patients were recruited from the Standard versus Ultrasound-guided Radial and Femoral Access (SURF) trial. Thirty transradial access (TRA) were compared with 30 control transfemoral patients. 2D color Doppler, 13-6 MHz transducer was performed at: distal radial, mid radial and brachial artery. Ultrasound was done pre-procedure, 1-week post-procedure and at 6 months for positive results. A separate investigator blinded to deidentified patients performed measurements using ImageJ program. Each site was measured 3 times and average taken. Findings classified into 4 types: (A) no stenosis (B) segmental stenosis [<10 mm length and >10% stenosis] (C) diffuse stenosis [>50mm length, >15% stenosis and intimal thickening >0.4 mm] (D) no flow.
Results: Both groups were similar in characteristics, including mean radial artery diameter (0.19 cm TRA vs. 0.18 cm control). All used 6F sheath. In TRA group, 83.3% had CA and 16.7% had PCI. There was no symptom or clinical evidence of vascular complications post-procedure. All radial pulses were palpable at follow up. Two patients (6.7%) developed type B stenosis at puncture site and persisted at 6 months. No common risk predictor identified.
Conclusion: Asymptomatic, subclinical stenosis at radial access site may occur at higher rates than expected. This may have implications on future arterial use or its conduit. Larger study is required to identify features that predict risk of stenosis. 
Heart And Lung Institute, The Prince Charles Hospital, Brisbane, Australia
Aim/objective: The aim of this study was to determine the outcomes of ultrasound-guided technique for patients undergoing percutaneous transfemoral transcatheter aortic valve implantation (TF-TAVI) to prevent vascular complications.
Method: We report a single centre analysis of 154 patients of a prospectively collected cohort between who underwent transfemoral TAVI using the balloon-expandable Edwards SAPIEN 3 transcatheter heart valve. Patients were divided into two groups (non ultrasound-guided puncture group who underwent TAVI n = 86 compared to those patients who underwent ultrasound-guided puncture n = 68.)
The incidence of major vascular complications as defined by The Valve Academic Research Consortium -2 Criteria (VARC2 criteria) and bleeding complications as defined by the Bleeding Academic Research Consortium (BARC) were used as outcome measures.
Results: The incidence of major access site related complications were low and were numerically reduced with ultrasound guided puncture (4.65% vs 0.0%; p = 0.135.) BARC Bleeding criteria greater or equal to 3 was similar between groups (2.33% vs 1.47%; p = NS).
Conclusion: This study demonstrates a numerical trend to improved outcomes following the use of ultrasound-guided percutaneous transfemoral puncture for TAVI. This technique has been shown to prevent vascular complications as defined by VARC2 criteria. 
